February 14, 2023
FDA: Class I recall of Skippack Medical Lab COVID-19 tests
Editor's Note
The Food and Drug Administration (FDA) on February 8 identified the recall by Universal Meditech Inc of its Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) as Class I, the most serious.
The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA.
Distribution dates were January 2022.
Free Daily News
- The Joint Commission revises CAH requirements to align with CMS
- Effect of union membership on nursing turnover, job satisfaction
- The Joint Commission updates requirements for addressing ethical issues
- CMS eliminates HCW COVID-19 vaccination requirements
- Mobilization associated with fewer postoperative complications, shorter hospital stays
- Is the ‘great resignation’ coming to a close?
- Effect of healthy sleep on risk of long COVID
- ChatGPT fails American College of Gastroenterology self-assessment tests
- US population growing older
- Binge drinking, night shift work doubled risk of COVID-19 infection in nurses during pandemic
- Thoracic Surgeon Pittsburgh, PA - Allegheny Health Network (AHN) - Pittsburgh, PA
- Director Thoracic Surgery Pittsburgh, PA - Allegheny Health Network (AHN) - Pittsburgh, PA
- Rocky Mountain Thoracic Surgery at Tertiary Center - Billings Clinic - Health System - Billings, MT
- Rocky Mountain Vascular Surgery: Generous Loan/Relo Repay, Outdoor Life - Billings Clinic - Health System - Billings, MT
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity